EPRXEupraxia Pharmaceuticals Inc.

Healthcare
$7.58+26% 1Y

The financials

Eupraxia Pharmaceuticals Inc. by the numbers

For the full year FY2025, revenue was $0 and net income −$39M.

Biotechnology

The closest names by size in the same industry

Compare peers
CTNM+3.7%
Contineum Therapeutics, Inc.
PROK+5.0%
PROKIDNEY CORP.
ARVN+0.80%
ARVINAS, INC.
ALT-2.4%
Altimmune, Inc.
ALLO-1.8%
Allogene Therapeutics, Inc.
PBYI+1.6%
PUMA BIOTECHNOLOGY, INC.